The retinoblastoma gene product (Rb) is a tumor suppressor that affects apoptosis paradoxically. Most sporadic cancers inactivate Rb by preferentially targeting the pathway that regulates Rb phosphorylation, resulting in resistance to apoptosis; this contrasts with Rb inactivation by mutation, which is associated with high rates of apoptosis. How phosphorylated Rb protects cells from apoptosis is not well understood, but there is evidence that Rb may sequester a pro-apoptotic nuclear factor. pp32 (ANP32A) is a pro-apoptotic nuclear phosphoprotein, the expression of which is commonly increased in cancer. We report that hyperphosphorylated Rb interacts with pp32 but not with the closely related proteins pp32r1 and pp32r2. We further demonstrate that pp32-Rb interaction inhibits the apoptotic activity of pp32 and stimulates proliferation. These results suggest a mechanism whereby cancer cells gain both a proliferative and survival advantage when Rb is inactivated by hyperphosphorylation.
The retinoblastoma gene product (Rb) is a tumor suppressor that affects apoptosis paradoxically. Most sporadic cancers inactivate Rb by preferentially targeting the pathway that regulates Rb phosphorylation, resulting in resistance to apoptosis; this contrasts with Rb inactivation by mutation, which is associated with high rates of apoptosis. How phosphorylated Rb protects cells from apoptosis is not well understood, but there is evidence that Rb may sequester a pro-apoptotic nuclear factor. pp32 (ANP32A) is a pro-apoptotic nuclear phosphoprotein, the expression of which is commonly increased in cancer. We report that hyperphosphorylated Rb interacts with pp32 but not with the closely related proteins pp32r1 and pp32r2. We further demonstrate that pp32-Rb interaction inhibits the apoptotic activity of pp32 and stimulates proliferation. These results suggest a mechanism whereby cancer cells gain both a proliferative and survival advantage when Rb is inactivated by hyperphosphorylation.
The retinoblastoma protein (Rb) 1 is a nuclear phosphoprotein that regulates proliferation, differentiation, and apoptosis. As a tumor suppressor, Rb inhibits proliferation by repressing E2F1-mediated transcription when hypophosphorylated. Hyperphosphorylation of Rb relieves E2F1 repression and allows cell cycle progression to occur (1) . The importance of Rb is underscored by the fact that Rb function is disrupted in virtually all human cancers (2) . Paradoxically and inconsistent with its role as a tumor suppressor, hyperphosphorylated wild-type Rb inhibits apoptosis in both cell culture and animal models (3) (4) (5) (6) (7) (8) (9) (10) . Because Rb inactivation is pivotal for carcinogenesis, this poses the problem of how cancer cells escape apoptosis when Rb function is disrupted.
Inherited cancers and cells in which Rb is inactivated by mutation have increased rates of both proliferation and apoptosis (11) . Most sporadic cancers preferentially inactivate Rb by hyperphosphorylation, which may occur through mutation of cyclin D, cdk4, or p16. Such cancers are generally slow growing and resistant to apoptosis induced by chemotherapy or radiation (12) . It is possible that in these cancers the tumor suppressor function of Rb is inhibited, whereas the anti-apoptotic function remains intact (13) . Inactivation by hyperphosphorylation might promote proliferation by increasing free E2F1, as well as inhibit apoptosis by retaining the anti-apoptotic function of Rb. This is consistent with evidence suggesting that it is the hyperphosphorylated form of Rb rather than Rb per se that protects cells from apoptosis (14) . The induction of apoptosis in various cell lines is accompanied by a shift in Rb from the hyperphosphorylated to the hypophosphorylated form (15, 16) . Rb dephosphorylation, which has been shown to be required for apoptosis, occurs in the early stage of apoptosis (17, 18) . Inhibition of Rb dephosphorylation prevents apoptosis, whereas induction of dephosphorylation leads to apoptosis (19) . In DBA/2 mice, increased levels of hyperphosphorylated Rb appear to mediate apoptotic resistance (20) . An increased level of hyperphosphorylated Rb is associated with a worse clinical outcome and greater chemoresistance as compared with Rb loss or normal levels of unphosphorylated Rb in patients with anaplastic large cell lymphoma (21) . These observations all point to a pivotal role for hyperphosphorylated Rb in inhibiting apoptosis.
Although the exact mechanism by which Rb inhibits apoptosis is unclear, it does not always require the inhibition of E2F1-mediated transcription by Rb. The increase in apoptosis seen in Rb-null embryos is only partially reversed in Rb and E2F1 double knock-outs (22) . A caspase-resistant Rb mutant, Rb-MI, inhibits apoptosis in response to tumor necrosis factor ␣-induced apoptosis by interfering with caspase 3 activation (23). These results led to the postulate that Rb binds to and sequesters a nuclear factor that stimulates caspase 3 activation (24) . Although Rb binds to Ͼ100 protein partners, the majority bind to the hypophosphorylated form (25) ; yet it is the hyperphosphorylated form that predominates in most sporadic cancers.
pp32 is a member of the ANP32 family of acidic, leucine-rich, nuclear phosphoproteins found in cells capable of self-renewal and in certain long-lived neuronal populations (26) . pp32 has been implicated in a number of cellular processes, including proliferation (27) , differentiation (28), caspase-dependent and caspase-independent apoptosis (29, 30) , suppression of transformation in vivo (31, 32) , inhibition of protein phosphatase 2A (33) , regulation of mRNA trafficking and stability in association with HuR (34) , and inhibition of acetyltransferases as part of the INHAT (inhibitor of acetyltransferases) complex (35) .
At a biologic level, pp32 inhibits transformation of rat embryo fibroblasts (36) , possibly through its pro-apoptotic activity. It accelerates caspase activation by stimulating the apoptosome, but the in vivo significance of this is unclear. In contradistinction to its pro-apoptotic and transformation inhibition functions, pp32 is highly expressed in cancer (37) . In fact, pp32 is more highly expressed in highly malignant prostatic adenocarcinomas with Gleason scores of Ն5 than in clinically indolent tumors with Gleason scores of Ͻ5 (38) . These data suggest that high levels of pp32 might foster increased malignancy. We report here that hyperphosphorylated Rb and pp32 associate in a specific complex. The pp32-Rb interaction inhibits the apoptotic activity of pp32 and promotes increased proliferation.
EXPERIMENTAL PROCEDURES
Construction of Vectors-All PCR reagents were purchased from Qiagen. pp32 truncation constructs were generated via PCR amplification of desired pp32 sequences. Primers were designed using the Stanford primer program (genome-www2.stanford.edu/cgi-bin/SGD/webprimer). All pp32 constructs utilized a common upstream primer, and all downstream primers lacked a stop codon to facilitate COOH-terminal V5 epitope tagging. Following amplification from pp32, pp32r1, or pp32r2 plasmids, products were cloned into the expression vector pcDNA3.1/V5-His Topo TA (Invitrogen) according to the manufacturer's instructions. pp32⌬201-360 was constructed in two stages. Bases 1-201 and 360 -747 were amplified separately. The upstream primer of bases 360 -747 and the downstream primer of bases 1-201 had NheI sites at their 5Ј-ends. Both amplicons were NheI-digested and ligated, and pp32 upstream and downstream primers were used to amplify the ligation products. The PCR products were then cloned into pcDNA3.1/V5-His Topo TA (Invitrogen). All constructs were verified by sequencing.
E2F1 and pRb plasmids were kind gifts from Fikret Sahin (Johns Hopkins) and Robert Weinberg (Massachussetts Institute of Technology), respectively. The Rb large pocket constructs WT-LP and PSM2T-LP were kind gifts from Erik Knudsen (University of Cincinnati). The pE2F-TA-Luc vector was purchased from Clontech.
Cell Culture and Transfections-HEK 293, HeLa, and NIH 3T3 cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen) with 10% fetal bovine serum (Invitrogen) and 1% penicillin/streptomycin (Invitrogen). Cells were passaged 2-3 times/week. All DNA transfections were carried out using FuGENE 6 (Roche Applied Science) as described by the manufacturer.
Antibodies-The antibodies used for this study were anti-pp32, anti-V5 (Invitrogen), anti-E2F (KH95, BD Biosciences), anti-Rb G3-245 (BD Biosciences), anti-Rb G99-549 (BD Biosciences), anti-Rb G99-2005 (BD Biosciences), anti-Rb C-15 (Santa Cruz Biotechnology), and polyclonal anti-RB 851 (gift from Erik Knudsen). The anti-phospho-Rb antibodies used were anti-S795 (Cell Signaling) and anti-T249/252, anti-T356, anti-S612, anti-S780, anti-S807/811, anti-T821, and anti-T826 (all from BIOSOURCE).
Immunoprecipitation and Immunoblotting-1 ϫ 10 6 HEK 293 cells were seeded onto a T-150 flask. 24 h later, cells were transfected with 15 g of the indicated plasmids. 48 h post-transfection, cells were harvested, washed twice with cold PBS, and lysed with an M-PER mammalian protein extraction reagent (Pierce) containing 1ϫ HALT protease inhibitor mixture (Pierce). Lysates were centrifuged at 4°C for 30 min at 16,000 ϫ g to remove particulate material. The supernatant was precleared for 2 h with protein A-agarose (Roche). The pre-cleared cell lysates were mixed with the indicated antibodies and protein A-or protein G-agarose (Roche Applied Science) and incubated at 4°C overnight. The next day the reaction mixture was washed three times with cold phosphate-buffered saline, boiled for 3 min, and eluted in 2ϫ SDS buffer. The eluted materials were subsequently analyzed by immunoblotting with the indicated antibodies.
Proteins were separated in NuPAGE 10% bis-Tris gel (Invitrogen) and electroblotted onto polyvinylidene difluoride membranes (Invitrogen). The immunoblot analysis used indicated specific antibodies and enhanced chemoluminescence (ECL)-based detection (Amersham Pharmacia Biotech). Where indicated, blots were stripped with Restore Western blot stripping buffer (Pierce) per the manufacturer's instructions.
Reporter Assays-For reporter assays, NIH 3T3 cells were transfected with 1 g of E2F-TA-LUC (Clontech), 0.5 g of E2F1, 0.5 g of pRb, and 1 g of pp32V5 or pp32⌬201-360V5 expression plasmids as indicated. In all of the samples, 50 ng of the reporter vector pRL-TK (Promega) was included for normalization of the transfection efficiency. Total transfected DNA was kept constant at 3 g with pcDNA 3.1 when necessary. 24 h after transfections, cells were lysed and assayed for luciferase activity using the Dual luciferase kit (Promega) per the manufacturer's protocol.
Statistical analysis of the reporter data was carried out by one-way analysis of variance followed by a Tukey multiple comparison post-test to compare individual pairs of data sets. The analysis was performed using GraphPad Prism software, version 4.0 (www.graphpad.com).
Colony Formation Assays-1.5 ϫ 10 5 NIH 3T3 or HeLa cells, as indicated, were seeded in 6-well plates overnight. 24 h later they were transfected with 1 g of DNA containing the indicated plasmids. Total transfected DNA was kept constant at 2 g with pcDNA 3.1 when necessary. 48 h after transfection, cells were split into a 100-mm dish containing Dulbecco's modified Eagle's medium and 1% penicillin/streptomycin supplemented with 1000 -500 g/ml G418 (Invitrogen). The cultures were fed every 3-4 days. After 2 weeks, the cells were fixed with 95% ethanol and stained with 0.5% crystal violet in 95% ethanol, the plates were photographed, and the colonies were counted.
Apoptosis Assays-1.5 ϫ 10 5 HeLa cells were seeded in 6-well plates overnight. 24 h later they were transfected with 1 g of DNA containing the indicated plasmids and 1 g of vector control plasmid where necessary for a total of 2 g of DNA. 48 h post-transfection cells were fixed with ice cold 100% methanol at Ϫ20°C for 15 min. After fixation, cells were stained with 10 g ml Ϫ1 Hoechst 33342 (Molecular Probes) for 10 min at 37°C. Samples were mounted with mounting medium containing Prolong anti-fade reagent (Molecular Probes). Apoptotic cells were identified and counted using a Nikon microscope equipped with an epi-illuminator and appropriate filters. The percentages of apoptotic cells were determined from 300 cells counted in each of three independent experiments.
RESULTS
We hypothesized that pp32 might interact with other proteins, such as Rb, that are involved in the regulation of pathways determining cell fate. To test this hypothesis, we screened for interactions by immunoprecipitation and identified Rb as a protein interacting with pp32.
When V5 epitope-tagged pp32 was expressed by transient transfection of mammalian cells, an interaction between endogenous Rb and pp32V5 was detected by Western blot analysis following immunoprecipitation with either an anti-V5 (Fig. 1A) or an anti-Rb antibody (Fig. 1B) . The interaction between Rb and pp32 can also be demonstrated in untransfected mammalian cells, including HeLa cells (Fig. 1C) , suggesting that it is physiologically relevant.
pp32 is made up of a nuclear localization signal, an acidic region, and a leucine-rich repeat (LRR) region that contains the nuclear export signal. Suppression of transformation and IN-HAT activity map to amino acids 150 -174, slightly N-terminal to the acidic region. LRRs generally mediate protein-protein interactions (39) , and the LRR of pp32 mediates its nucleocytoplasmic shuttling via binding to CRM1 (34) . The Rb-binding region of pp32 was mapped using V5 epitope-tagged constructs lacking the acidic region, the LRR, or both (Fig. 1D) . Whereas deletion of the acidic region had no effect, the deletion of nucleotides 201-360 encoding amino acids 67-120 in the LRR of pp32 abolished Rb binding (Fig. 1E) . Because the expression of pp32V5-201 appeared to be low in the lysate shown in Fig. 1E , the experiment was repeated with a higher expression level (Fig. 1F) , yielding the identical result.
As Rb functions are regulated by phosphorylation, we next determined which form of Rb (hypophosphorylated or hyperphosphorylated) interacted with pp32. V5 epitope-tagged pp32 was transiently expressed in HEK 293 cells, and the anti-V5 antibody was used to immunoprecipitate pp32V5. pp32 coimmunoprecipitated with hyperphosphorylated Rb because the V5 immunoprecipitates did not contain any hypophosphorylated Rb (Fig. 2, A and B) .
Although not all Rb phosphorylation sites in vivo have been identified, Rb has at least 16 predicted cyclin-dependent kinase phosphorylation sites (40) . Differentially phosphorylated forms of Rb appear to exist in cells (41) (42) . To determine the specific pp32-Rb Interaction Inhibits pp32 Apoptotic Activityphosphorylated form of Rb that binds to pp32, various phospho-specific Rb antibodies were used to probe an anti-V5 immunoprecipitate of pp32V5. These immunoprecipitates specifically reacted with an anti-phosphoThr 826 Rb antibody (Fig. 2C) . To further confirm that Rb phosphorylation at Thr 826 is necessary for pp32 binding, we used the Rb large pocket constructs WT-LP and PSM2T-LP, which have been described previously (42) . WT-LP encodes the wild-type large pocket fragment of Rb (amino acids 379 -928), and PSM2T-LP is a double T821A/T826A large pocket mutant. pp32V5 was cotransfected with either control, WT-LP, or PSM2T-LP constructs into HEK 293 cells, and the anti-V5 antibody was used to immunoprecipitate pp32V5 complexes. pp32 co-immunoprecipitated with WT-LP but not with PSM2T-LP, suggesting that pp32-Rb interaction requires Rb phosphorylation at Thr 826 (Fig. 2D ). Because hyperphosphorylated Rb is unable to repress E2F1-mediated transcription, we used an E2F-luciferase reporter plasmid to investigate whether pp32 could increase E2F1-mediated transcriptional activity. Overexpression of pp32 consistently resulted in 3-5-fold increased transactivation of the E2F-luciferase promoter in the presence of excess E2F1 (p Ͻ 0.001 for E2F1 plus pp32 versus control; Fig. 3 ). This increased transcriptional activation could be decreased by overexpression of Rb (p Ͻ 0.001 for E2F1 plus pp32 versus E2F1 plus pRB plus pp32) and completely abolished by disruption of the interaction between Rb and pp32 via the deletion of amino acids 67-120 (p Ͻ 0.001 for E2F1 plus pp32 versus E2F1 plus pp32⌬201-360). Cells transfected with the reporter plus pp32 alone, E2F1 alone, E2F1 plus Rb, E2F1 plus pRB plus pp32, E2F1 plus pp32⌬201-360, or E2F1 plus pRB plus pp32⌬201-360 did not differ significantly from the control or from one another (p Ͼ 0.05). These results suggest that pp32 is able to sequester hyperphosphorylated Rb and thereby increase free E2F1. At the doses used in these assays, pp32 did not increase E2F-luciferase transactivation in the absence of E2F1 overexpression. It is probable that because there was enough endogenous Rb to bind E2F1 and pp32, the sequestration of Rb by pp32 was only unmasked when excess E2F1 was added to the system. The fact that pp32 has an acidic domain found in transcriptional activators raised the possibility that pp32 directly interacts with E2F1 to increase E2F1-mediated transcription. pp32 was transiently overexpressed in HEK 293 cells, and cell lysates were immunoprecipitated with E2F1 and Rb antibodies. Although pp32 was detected in Rb immunoprecipitates, it was absent in E2F1 immunoprecipitates (data not shown). These results rule out both direct and indirect interactions between pp32 and E2F1. 
pp32-Rb Interaction Inhibits pp32 Apoptotic Activity
Because pp32 is pro-apoptotic whereas Rb is anti-apoptotic, we investigated the effect of Rb on the apoptotic function of pp32. In mammalian cells, transient overexpression of pp32 resulted in increased apoptosis as assessed by Hoechst staining (Fig. 4A) . The apoptotic effect of pp32 was abolished by the coexpression of Rb. To further evaluate the effect of Rb on the pro-apoptotic activity of pp32 in mammalian cells, we performed a colony formation assay. pp32 overexpression resulted in a decrease in colony formation compared with vector control. Cotransfection of Rb with pp32 abrogated the pp32-mediated decrease in colony formation (Fig. 4B) . The pp32⌬201-360 construct yielded greatly diminished levels of apoptosis, which precluded the demonstration that it was insensitive to the addition of Rb; this experiment would have provided more direct evidence that the apoptotic effects of pp32 are inhibited by Rb rather than by another mechanism.
NIH 3T3 is a classic cell system for testing various transformation agents. Overexpression of the v-H-Ras protein in NIH 3T3 cells results in cellular transformation and the accelerated cell cycle progression associated with an increased level of cyclin D, which increases hyperphosphorylated Rb levels (43) . To examine the effect of the pp32-Rb interaction on mitogenesis, we transfected activated H-ras, pp32, and pRb into NIH 3T3 cells. Coexpression of Ras and pp32 resulted in a slight decrease in colony formation, whereas coexpression of Ras, pp32, and Rb resulted in markedly increased colony formation compared with the Ras only control (Fig. 4C) .
Whereas pp32 inhibits transformation, pp32r1 (ANP32C) and pp32r2 (ANP32D), both highly homologous to pp32 at the protein level (87.7 and 89.3% respectively), are tumorigenic (44) . We therefore explored the possibility of an interaction between these family members and Rb. pp32r1 and r2 were V5 epitope-tagged and overexpressed in HEK 293 cells. Equal amounts of cell lysates were immunoprecipitated with anti-Rb and immunoblotted with anti-V5. Surprisingly, pp32r1 and pp32r2 did not interact with Rb (Fig. 5 ) despite high conservation within amino acids 67-120 of the LRR region (88.9 and 90.7% identical respectively), suggesting that the interaction between Rb and pp32 is highly specific.
DISCUSSION
Our data demonstrate an interaction between pp32 and hyperphosphorylated Rb. This interaction is mediated via the LRR of pp32, which also mediates its binding to CRM1 and nucleocytoplasmic shuttling. We have not established whether the pp32-Rb interaction is direct or whether it occurs through the intermediacy of other molecules. Nevertheless, we do show that pp32-Rb interaction is associated with increased E2F1 activity, inhibition of the apoptotic activity of pp32, and increased colony formation in vivo.
It is attractive to speculate that Rb binding to the LRR of pp32 in the nucleus prevents binding of CRM1, thereby inhibiting the nucleocytoplasmic shuttling of pp32. The effect of Rb binding on the localization of pp32 has not been directly demonstrated. Because pp32 localizes preferentially to the nucleus,
FIG. 2. pp32 binds preferentially to Rb phosphorylated on Thr

826
. A, HEK 293 cells were transfected with pp32V5 or shamtransfected. Equal amounts of transfected cell extracts were precipitated with an anti-V5 antibody or an anti-neuron-specific enolase antibody (NSE) control as indicated. Equal amounts of sham-transfected cell extracts were precipitated with total Rb (C-15) or a control (AChE) antibody as indicated. The presence of hypophosphorylated Rb (Hypo Rb) in the immunoprecipitates (IP) was analyzed by immunoblotting using an antibody specific for hypophosphorylated Rb (G99-549) . B, the blot in panel A was stripped and re-probed with total Rb (G3-245) antibody. C, HEK 293 cells were transfected with pp32V5 or LacZV5 (pcDNA3.1) or sham-transfected as indicated. Equal amounts of pp32V5-and LacZV5-transfected cell extracts were precipitated with anti-V5. As a positive control, sham transfected cell extracts were precipitated with antibody to total Rb (G3-245); this control, which precipitates considerably more Rb, is designated Sham. The presence of specific phosphorylated forms of Rb in the immunoprecipitates was analyzed by immunoblotting using the indicated anti-phospho-Rb antibodies. D, HEK 293 cells were cotransfected with the pp32V5 and control, WT-LP, or PSM2T-LP as indicated. Equal amounts of cell extracts were precipitated with an anti-V5 antibody. Top, the presence of WT-LP or PSM2T-LP in immunoprecipitates (IP) was probed by Western blot analysis using an anti-Rb antibody (851). The arrow on the right indicates the position of the Rb large pocket fragment. The lower band present in all three lanes is the immunoglobulin heavy chain, which serves as a loading control. Middle, anti-V5 immunoprecipitates were subjected to Western blot analysis with anti-V5 antibody to confirm pp32V5 immunoprecipitation. Bottom, cell extracts were subjected to Western blotting with an anti-Rb antibody (851) to confirm expression of WT-LP and PSM2T-LP.
FIG. 3. pp32 increases E2F1-mediated transcriptional activity.
NIH 3T3 cells were transiently transfected with E2F-luciferase reporter vector (pE2F-TA-Luc) and, where indicated, E2F1, pRb, pp32V5, or pp32⌬201-360V5 expression vectors. Data are presented as the mean Ϯ S.E. from three independent experiments performed in duplicate.
pp32-Rb Interaction Inhibits pp32 Apoptotic Activity
shuttling has only been demonstrated in heterokaryon experiments (34) . Direct demonstration would require the analysis of a series of heterokaryons with a number of stably transfected cell lines, where clear interpretation would be difficult. Based upon the available information, we propose a model whereby in normal cells increased pp32 is able to shuttle to the cytoplasm to promote apoptosis by stimulating the apoptosome, but in cancer cells increased hyperphosphorylated Rb sequesters pp32 in the nucleus, resulting in apoptotic resistance, increased free E2F1, and proliferation (Fig. 6) . This model suggests a mechanism whereby cancer cells could escape apoptosis when Rb is inactivated by hyperphosphorylation. This model could also explain the seemingly paradoxical high level expression of pp32 in high grade cancer. Cancer cells would therefore preferentially inactivate Rb by hyperphosphorylation, gaining both growth and survival advantages by doing so.
Given the important role of apoptosis in tumorigenesis, our results suggest a mechanism whereby the inhibition of apoptosis by Rb might be exploited in cancer cells to promote the survival of transformed cells. Inhibitors of the pp32-Rb interaction might be useful for restoring apoptotic sensitivity to cancer cells, thereby potentiating chemotherapeutic agents. 
FIG. 4.
Association between Rb and pp32 correlates with the inhibition of pp32 apoptotic activity. A, pp32-induced apoptosis is abrogated by Rb in mammalian cells. HeLa cells were transfected with expression plasmids encoding the indicated proteins. Nuclei were stained with Hoechst stain and examined by immunofluorescence microscopy for characteristics of apoptosis (membrane blebbing, chromatin condensation, and pyknosis). Cell death was quantified in HeLa cells transfected with the indicated expression constructs. The data (mean Ϯ S.E.) are the percentage of nuclei counted with apoptotic morphology (n equals at least three experiments). B, duplicate plates of HeLa cells were transfected with control, pp32, or pRb expression plasmids as indicated and subjected to colony formation assay. Plates were stained with methylene blue, and the total number of G418-resistant colonies was counted after 14 days of selection. A representative experiment is shown. The bar graph (mean Ϯ S.E.) shows the percentage change in colony formation efficiency with the colony counts normalized against the vector only control (n equals at least three experiments in duplicate). C, duplicate plates of NIH 3T3 cells were transfected with Ras, pp32, or pRb expression plasmids as indicated and subjected to colony formation assay. Plates were stained with methylene blue and photographed after 14 days of G418 selection.
